echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Nat Med: Long-Term Cardiovascular Outcomes in COVID-19 Patients

    Nat Med: Long-Term Cardiovascular Outcomes in COVID-19 Patients

    • Last Update: 2022-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The acute sequelae of coronavirus disease 2019 ( COVID-19 ) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may involve the lungs and several extrapulmonary organs, including the cardiovascular system .


    Infection with COVID-19 blood vessels

    A comprehensive assessment of the acute cardiovascular sequelae of COVID-19 has not yet been performed, and various therapeutic approaches (ambulatory, hospitalized, and intensive care unit admission) for acute infection are lacking


    In a study published today in the top medical journal Nature Medicine, researchers used the U.


    cardiovascular events

    Researchers found that 30 days after SARS-CoV-2 infection, COVID-19 patients were at increased risk of developing cardiovascular disease, including cerebrovascular disease, arrhythmias , ischemic and nonischemic heart disease, pericarditis, myocarditis, Heart failure and thromboembolic disease


    arrhythmia thrombosis

    Thus, this study provides evidence that the risk and 1-year burden of cardiovascular disease in survivors of acute COVID-19 is substantial


    This study provides evidence that the risk and 1-year burden of cardiovascular disease in survivors of acute COVID-19 is substantial


    Original source:

    Yan Xie, et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.